GALT

Neutral

[Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity

Galectin Therapeutics director Harold H. Shlevin exercised stock options for 30,000 shares and simultaneously sold them in open-market transactions on...

Stock Titan 1 hour ago 0

Neutral

Galectin Therapeutics director sells $150,890 in common stock By Investing.com

Harold H. Shlevin, a director at Galectin Therapeutics Inc. (NASDAQ: GALT), recently sold 30,000 shares of the company's common stock for approximatel...

Investing.com Canada 43 mins ago 0

Neutral

Form 4 Galectin Therapeutics Inc For: 30 June By Investing.com

This article from Investing.com reports that Galectin Therapeutics Inc. filed a Form 4 for the period ending June 30th. The filing is a standard requi...

Investing.com Canada 43 mins ago 0

Neutral

Galectin Therapeutics (GALT) CMO exits 52,037 shares in pre-planned sale

Jamil Khurram, the Chief Medical Officer of Galectin Therapeutics (GALT), exercised and sold 52,037 shares of common stock in pre-planned transactions...

Stock Titan 31 mins ago 0